Table 3 Distribution and incidence densities of 263 HAI
Kind of healthcare-associated infection (HAI) | No. (Proportion) | ID |
|---|---|---|
All HAIs | 263 (100%) | 4.80 |
Bloodstream infections (BSI) | 153 (58%) | 2.79 |
Laboratory-confirmed (blood-culture positive) BSI | 138 (52%) | 2.52 |
Bacteremia | 95 (36%) | 1.73 |
Sepsis | 35 (13%) | 0.64 |
Septic shock | 5 (2%) | 0.09 |
Septic shock with multiorgan failure | 3 (1%) | 0.05 |
Blood-culture negative BSI | 15 (6%) | 0.27 |
Clinically defined sepsis | 10 (4%) | 0.18 |
Clinically defined septic shock | 1 (0%) | 0.02 |
Clinically defined septic shock with multiorgan failure | 4 (2%) | 0.07 |
Radiologically confirmed pneumonia | 20 (8%) | 0.36 |
Invasive aspergillosis | 26 (10%) | 0.47 |
Pulmonary invasive aspergillosis | 21 (8%) | 0.38 |
Proven pulmonary case of invasive aspergillosis | 6 (2%) | 0.11 |
Probable pulmonary case of invasive aspergillosis | 15 (6%) | 0.27 |
Other localization (sinus, central nervous system) | 5 (2%) | 0.09 |
Respiratory syncytial virus (RSV) infection | 2 (1%) | 0.04 |
Surgical site infection | 15 (6%) | 0.27 |
Early (≤ 14 days from intervention) surgical site infection | 6 (2%) | 0.11 |
Late (> 14 days from intervention) surgical site infection | 9 (3%) | 0.16 |
Clostridium difficile associated enterocolitis | 24 (9%) | 0.44 |
Preceding i.v. antibiotics within 14 days | 11 (4%) | 0.20 |
No preceding i.v. antibiotics within 14 days | 13 (5%) | 0.24 |
Rotavirus associated enterocolitis | 6 (2%) | 0.11 |
Urinary tract infection (UTI) | 8 (3%) | 0.15 |
UTI related to urinary tract catheter | 3 (1%) | 0.05 |
UTI not related to urinary tract catheter | 5 (2%) | 0.09 |
Ventriculitis related to external CSF drainage | 1 (0%) | 0.02 |
Local infections at the central venous access device exit site | 8 (3%) | 0.15 |